Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
902 Ergebnisse
| MN8XDE |  | Regeneron Pharmaceuticals Inc./OS/Call [750]/MS | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | 800,000 | - | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN8XDF | | Regeneron Pharmaceuticals Inc./OS/Call [750]/MS | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | 800,000 | - | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MR3CF3 | | Regeneron Pharmaceuticals Inc./OS/Call [750]/MS | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 51,026 % | 0,592 | -0,009 | 2,399 | 16.06.2028 | 0,010 | Morgan Stanley | |
| MR3SHL | | Regeneron Pharmaceuticals Inc./OS/Call [750]/MS | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | 800,000 | - | - | - | - | 15.01.2027 | 0,100 | Morgan Stanley | |
| MR3SQ6 | | Regeneron Pharmaceuticals Inc./OS/Call [750]/MS | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | 800,000 | - | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| FA8MG9 | Regeneron Pharmaceuticals Inc./OS/Call [750]/SOC | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,508 % | 0,281 | -0,192 | 11,538 | 18.09.2026 | 0,100 | Société Générale | ||
| FA8MHA | Regeneron Pharmaceuticals Inc./OS/Call [750]/SOC | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,577 % | 0,401 | -0,145 | 6,633 | 18.12.2026 | 0,100 | Société Générale | ||
| FD48N8 | Regeneron Pharmaceuticals Inc./OS/Call [750]/SOC | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,167 % | 0,411 | -0,114 | 5,295 | 19.03.2027 | 0,100 | Société Générale | ||
| FD51EU | Regeneron Pharmaceuticals Inc./OS/Call [750]/SOC | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,782 % | 0,458 | -0,103 | 4,371 | 17.06.2027 | 0,100 | Société Générale | ||
| FE23H6 | Regeneron Pharmaceuticals Inc./OS/Call [750]/SOC | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,620 % | 0,525 | -0,085 | 3,248 | 21.01.2028 | 0,100 | Société Générale | ||
| VJ8TZM | | Regeneron Pharmaceuticals Inc./OS/Call [750]/VONT | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,225 % | 0,397 | -0,014 | 6,714 | 18.12.2026 | 0,010 | Vontobel | |
| VY3N32 | | Regeneron Pharmaceuticals Inc./OS/Call [750]/VONT | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,762 % | 0,157 | -0,021 | 15,762 | 21.08.2026 | 0,010 | Vontobel | |
| VY5LQ5 | | Regeneron Pharmaceuticals Inc./OS/Call [750]/VONT | - | - | 750,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,251 % | 0,217 | -0,017 | 12,040 | 18.09.2026 | 0,010 | Vontobel | |
| GW02RU | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,397 % | 0,484 | -0,011 | 4,207 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW02S9 | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,100 % | 0,478 | -0,009 | 3,788 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02W5 | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,224 % | 0,402 | -0,012 | 5,219 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW061B | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,094 % | 0,517 | -0,009 | 3,244 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0F | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,003 % | 0,536 | -0,009 | 3,270 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J3U | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,976 % | 0,507 | -0,009 | 3,363 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K4J | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,671 % | 0,448 | -0,010 | 4,335 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K4S | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,158 % | 0,516 | -0,009 | 3,241 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K57 | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,510 % | 0,479 | -0,009 | 3,751 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW3SCA | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,304 % | 0,554 | -0,008 | 3,009 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QFC | Regeneron Pharmaceuticals Inc./OS/Call [760]/GOLDS | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,514 % | 0,547 | -0,008 | 2,869 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JZ6N9N | Regeneron Pharmaceuticals Inc./OS/Call [760]/JPMD | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,240 % | 0,343 | -0,012 | 6,761 | 15.01.2027 | 0,010 | JP Morgan | ||
| JE1VY5 | Regeneron Pharmaceuticals Inc./OS/Call [760]/JPMD | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,021 % | 0,372 | -0,014 | 7,097 | 18.12.2026 | 0,010 | JP Morgan | ||
| JE1X3A | Regeneron Pharmaceuticals Inc./OS/Call [760]/JPMD | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,193 % | 0,441 | -0,012 | 5,124 | 19.03.2027 | 0,010 | JP Morgan | ||
| JE7VPC | Regeneron Pharmaceuticals Inc./OS/Call [760]/JPMD | - | - | 760,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,678 % | 0,292 | -0,013 | 8,369 | 20.11.2026 | 0,010 | JP Morgan | ||
| GW02RE | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,227 % | 0,467 | -0,009 | 3,816 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02RG | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,315 % | 0,469 | -0,011 | 4,272 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW02SD | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,795 % | 0,385 | -0,011 | 5,360 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0619 | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,153 % | 0,534 | -0,009 | 3,189 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0R | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,971 % | 0,525 | -0,009 | 3,305 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1J1U | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,811 % | 0,495 | -0,009 | 3,409 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K49 | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,227 % | 0,467 | -0,009 | 3,816 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4V | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,131 % | 0,505 | -0,009 | 3,276 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K5B | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,315 % | 0,469 | -0,011 | 4,272 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3SBS | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,167 % | 0,545 | -0,008 | 3,043 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QFB | Regeneron Pharmaceuticals Inc./OS/Call [770]/GOLDS | - | - | 770,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,400 % | 0,538 | -0,008 | 2,900 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JF83JZ | Regeneron Pharmaceuticals Inc./OS/Call [775]/JPM | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,112 % | 0,336 | -0,013 | 7,349 | 18.12.2026 | 0,010 | JP Morgan | ||
| JU1UVM | Regeneron Pharmaceuticals Inc./OS/Call [775]/JPM | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,010 % | 0,152 | -0,013 | 13,578 | 18.09.2026 | 0,010 | JP Morgan | ||
| MJ5C64 | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,393 % | 0,303 | -0,013 | 7,238 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM7L6L | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,985 % | 0,434 | -0,011 | 4,277 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM7L6M | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 42,682 % | 0,182 | -0,016 | 11,670 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1HGR | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,406 % | 0,511 | -0,010 | 3,105 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6F47 | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,583 % | 0,387 | -0,012 | 5,147 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR3CF4 | | Regeneron Pharmaceuticals Inc./OS/Call [775]/MS | - | - | 775,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,392 % | 0,570 | -0,009 | 2,465 | 16.06.2028 | 0,010 | Morgan Stanley | |
| GW02RC | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,145 % | 0,454 | -0,009 | 3,870 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02SC | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,557 % | 0,366 | -0,011 | 5,491 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW02UV | Regeneron Pharmaceuticals Inc./OS/Call [780]/GOLDS | - | - | 780,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,871 % | 0,424 | -0,010 | 4,416 | 17.06.2027 | 0,010 | Goldman Sachs |